2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Retention
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Pleural Neoplasms
1
Pleural Effusion, Malignant
1
Pleural Effusion
1
Lung Neoplasms
1
Lower Urinary Tract Symptoms
1
Ascites
1
Interventions
Dutasteride
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Transurethral Resection of Prostate
2
Therapeutics
2
Radiotherapy
2
Prostatectomy
2
Blood Specimen Collection
2
proxalutamide
1
polyphenon E
1
mirabegron
1
Urination
1
TroVax
1
Transurethral Resection of Bladder
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Psychiatric Rehabilitation
1
Prostate-Specific Antigen
1
Papaverine
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Magnetic Resonance Spectroscopy
1
Lycopene
1
Levofloxacin
1
Finasteride
1
Electroacupuncture
1
Doxazosin
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Hyperplasia
×
Catheters, Indwelling
×
Clear all
NCT05851521
2023-05-09
HERMES
Lyx Institute
Phase NA
Unknown
120 enrolled